Asymmetric synthesis of (R)-(+)-[[(2-bromoethyl)amino]methyl]-2-nitro-1H-imidazole-[1-14C]-ethanol monohydrobromide
β Scribed by I. Victor Ekhato
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- French
- Weight
- 458 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
β¦ Synopsis
SUMMARY
The enantioselective synthesis of ((R)-(+)-2-() tert-butyldiphenylsiloxylmethyl ()\left[{ }^{14} \mathrm{C}\right]) oxirane from ({ }^{14} \mathrm{C})-labeled barium carbonate was accomplished. This labeled oxirane facilitated an asymmetric synthesis ((R)-(+))-[[(2-bromoethyl)amino]methyl]-2-nitro-1 (\mathrm{H})-imidazole-[ (\left[1-{ }^{14} \mathrm{C}\right])-ethanol monohydrobromide (CI-1010), a potent hypoxic cell selective radiosensizing anti-cancer agent. From labeled barium carbonate the labeled oxirane was prepared in (26.2 %) yield, and this gave the target labeled CI-1010 in (17 %) yield.
π SIMILAR VOLUMES
The synthesis of N,"-bis- (2-[(5-bromo-2-[ 1-14CIhexyl-1H-benz[de]isoquinolin-1,3(2H)-dion-6-yl)amino]ethyl}hexanediamide from 1-[ l-14C]-hexylamine and 4chloro-1 &naphthalic anhydride is described. The anhydride is first converted to the 4-chloro-N-[ 1-14C]hexyl-l,8-naphthalimide (2) by condensatio